FINWIRES · TerminalLIVE
FINWIRES

B. Riley Adjusts Opus Genetics Price Target to $10 From $9, Maintains Buy Rating

By

Price: $5.18, Change: $+0.51, Percent Change: +10.92%

Related Articles